Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10,301 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of standardized prophylactic high-dose and intrathecal methotrexate for DLBCL with a high risk of CNS relapse.
Akimoto M, Miyazaki T, Takahashi H, Saigusa Y, Takeda T, Hibino Y, Tokunaga M, Ohashi T, Matsumura A, Teshigawara H, Suzuki T, Teranaka H, Nakajima Y, Matsumoto K, Hashimoto C, Fujimaki K, Fujita H, Sakai R, Fujisawa S, Nakajima H. Akimoto M, et al. Among authors: matsumoto k. Int J Hematol. 2024 Feb;119(2):164-172. doi: 10.1007/s12185-023-03700-0. Epub 2024 Jan 17. Int J Hematol. 2024. PMID: 38233702
Retrospective comparison of mobilization methods for autologous stem cell transplantation in multiple myeloma.
Nakasone H, Kanda Y, Ueda T, Matsumoto K, Shimizu N, Minami J, Sakai R, Hagihara M, Yokota A, Oshima K, Tsukada Y, Tachibana T, Nakaseko C, Fujisawa S, Yano S, Fujita H, Takahashi S, Kanamori H, Okamoto S; Kanto Study Group of Cell Therapy. Nakasone H, et al. Among authors: matsumoto k. Am J Hematol. 2009 Dec;84(12):809-14. doi: 10.1002/ajh.21552. Am J Hematol. 2009. PMID: 19862826 Free article.
Serum HO-1 is useful to make differential diagnosis of secondary hemophagocytic syndrome from other similar hematological conditions.
Miyazaki T, Kirino Y, Takeno M, Hama M, Ushihama A, Watanabe R, Takase K, Tachibana T, Matsumoto K, Tanaka M, Yamaji S, Ideguchi H, Tomita N, Fujita H, Ohno S, Ueda A, Ishigatsubo Y. Miyazaki T, et al. Among authors: matsumoto k. Int J Hematol. 2010 Mar;91(2):229-37. doi: 10.1007/s12185-010-0495-y. Epub 2010 Jan 22. Int J Hematol. 2010. PMID: 20091384
Primary hepatic peripheral T-cell lymphoma treated with corticosteroid.
Miyashita K, Tomita N, Oshiro H, Matsumoto C, Nakajima Y, Ito S, Matsumoto K, Fujita H, Ishigatsubo Y. Miyashita K, et al. Among authors: matsumoto k, matsumoto c. Intern Med. 2011;50(6):617-20. doi: 10.2169/internalmedicine.50.4686. Epub 2011 Mar 15. Intern Med. 2011. PMID: 21422689 Free article. Review.
Clinical significance of minimal residual disease detected by multidimensional flow cytometry: serial monitoring after allogeneic stem cell transplantation for acute leukemia.
Miyazaki T, Fujita H, Fujimaki K, Hosoyama T, Watanabe R, Tachibana T, Fujita A, Matsumoto K, Tanaka M, Koharazawa H, Taguchi J, Tomita N, Sakai R, Fujisawa S, Kanamori H, Ishigatsubo Y. Miyazaki T, et al. Among authors: matsumoto k. Leuk Res. 2012 Aug;36(8):998-1003. doi: 10.1016/j.leukres.2012.04.005. Epub 2012 Apr 30. Leuk Res. 2012. PMID: 22551655
Upfront autologous stem cell transplantation for untreated high-risk diffuse large B-cell lymphoma in patients up to 60 years of age.
Takasaki H, Hashimoto C, Fujita A, Matsumoto K, Taguchi J, Kuwabara H, Yamazaki E, Koharazawa H, Fujita H, Fujisawa S, Ishii Y, Yamamoto W, Motomura S, Tomita N, Ishigatsubo Y, Sakai R. Takasaki H, et al. Among authors: matsumoto k. Clin Lymphoma Myeloma Leuk. 2013 Aug;13(4):404-9. doi: 10.1016/j.clml.2013.03.003. Epub 2013 Jun 10. Clin Lymphoma Myeloma Leuk. 2013. PMID: 23763919
Validation of the European Group for Blood and Marrow Transplantation (EBMT) risk score in patients receiving allogeneic hematopoietic stem cell transplantation at a single center in Japan.
Numata A, Tanaka M, Matsumoto K, Takasaki H, Tachibana T, Fujimaki K, Sakai R, Fujisawa S, Tomita N, Fujita H, Maruta A, Ishigatsubo Y, Kanamori H. Numata A, et al. Among authors: matsumoto k. Clin Transplant. 2014 Apr;28(4):403-9. doi: 10.1111/ctr.12324. Epub 2014 Mar 21. Clin Transplant. 2014. PMID: 24655161
Emergence of del(20q) in a patient in molecular remission of chronic myelogenous leukemia during imatinib treatment, with reduction following imatinib discontinuation.
Numata A, Kajiyama R, Itabashi M, Ishii Y, Yamamoto W, Motohashi K, Matsumoto K, Hagihara M, Ishigatsubo Y, Fujisawa S. Numata A, et al. Among authors: matsumoto k. Leuk Lymphoma. 2016;57(1):201-2. doi: 10.3109/10428194.2015.1037763. Epub 2015 May 12. Leuk Lymphoma. 2016. PMID: 25860242 No abstract available.
10,301 results
You have reached the last available page of results. Please see the User Guide for more information.